News

Deepak Bhatt, MD, executive director of Interventional Cardiovascular Programs at Brigham and Women's Hospital, offers perspective on the THEMIS and THEMIS-PCI trials.

A study from the University of California San Francisco found that patients with HIV were at an 80% increased risk of suffering from atrial fibrillation.

Dhruv Kazi, MD, of Beth Israel Deaconess Medical Center, discusses a recent study he led into the cost-effectiveness of polypill and why we do not see the approach applied to cardiovascular disease in the US.

Suraj Kapa, MD, takes part in an episode of DocTalk where he discusses the results of a recent study he led and how to implement technology into cardiology in a way that benefits patients and physicians.

Investigators report positive results using esketamine spray to treat patients with major depressive disorder.

In a retrospective study using the data of 20,741 patients, investigators discover the primary cause of emergency department visits for geriatric patients is head trauma.

The inaugural episode of the DocTalk Podcast features a conversation about transcatheter aortic valve replacement with two cardiologists from Brigham and Women's Hospital.

Investigators submit recommendations for physicians for Parkinson disease reflecting recent advancements, including a new section on palliative care.

How a pattern of poor sleep could begin a cycle of worsened respiratory and cardiovascular health.

Dr. Rizzo provides a look into the current methods of COPD screening, and how patient treatment potential is changed.

A study from the AHA's Hypertension Scientific Sessions revealed first- and second-year medical students have a 2.4 higher risk of stage 2 hypertension compared to the general public.

The approval for interstitial lung disease associated with systemic sclerosis or scleroderma makes nintedanib the first therapy for the rare condition.

Investigators find that sofosbuvir is less effective on some HCV infections because of certain amino acid substitutions.

A new extended trial for the liquid immunotherapy shows two-thirds of allergic children were able to consume at least 750 mg of peanut after 3-5 years.

A study of human gut bacteria suggests that high blood pressure with depression may be a completely different disease than high blood pressure without depression.

A Q&A with Brett Carroll, MD, director of Vascular Medicine at Beth Israel Deaconess Medical Center, as he discusses stroke management, DOACs, and warfarin.

A study from the AHA's 2019 Hypertension Scientific Sessions revealed that hypertension was linked to cognitive decline in older patients, but antihypertensive treatment could mitigate this impact.

Particle-depleted diesel exhaust may impair a person's lung function worse than just standard diesel exhaust—while also exposing them to more NO2.

Benzodiazepines are a common yet not very well understood drug class for elderly patients with insomnia.

An analysis of CREDENCE, EMPA-REG, the CANVAS Program, and DECLARE-TIMI 58 found SGLT2 inhibitor use reduced dialysis, transplantation, or death due to kidney disease by 33%.

In a double-blind, phase 2 trial, investigators find that SAGE-17 results in a reduction of depressive symptoms after 2 weeks.

Using a variety of tests to measure cognitive changes, investigators find that gender and education level does not impact cognitive decline as much as health and lifestyle factors.

How do at-risk exacerbation patients present, and what developing therapies could benefit them?

The DocTalk Podcast, a weekly conversation with leaders and experts in medicine, will launch with 3 new episodes on September 9.

Initial PCSK9 inhibitor plus statin therapy helped hospitalized patients achieve LDL-C

In a 53-patient observational study, investigators discover they can safely transplant a HCV-infected kidney into a HCV-negative recipients.

A recent study found that county-level poverty prevalence correlated with both heart failure and coronary heart disease mortality rates.

A pair of phase 3 trials show the single-dose oral drug could have expanded benefits for influenza, just months before an sNDA ruling.